10x Genomics, Inc. — Director's Dealing 2019

Sep 12, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2019-09-11

Reporting Person: Conley Paul A. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-09-11	Stock Option (right to buy)	$39.00	A	40000	Acquired	2029-09-11	Class A Common Stock (40000)	Direct

Footnotes

F1: This option, granted pursuant to the Issuer's 2019 Omnibus Incentive Plan, vests as to one thirty-sixth of the shares on October 11, 2019 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.